Related references
Note: Only part of the references are listed.HMG - CoA reductase inhibition mediated hypocholesterolemic potential of myricetin and quercetin: in-silico and in-vivo studies
Priyanka Riyad et al.
CYTA-JOURNAL OF FOOD (2023)
Molecular dynamic study of SARS-CoV-2 with various S protein mutations and their effect on thermodynamic properties
Mohnad Abdalla et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2022)
Bioinformatics approaches identified dasatinib and bortezomib inhibit the activity of MCM7 protein as a potential treatment against human cancer
Abdus Samad et al.
SCIENTIFIC REPORTS (2022)
Lipid Lowering Therapy: An Era Beyond Statins
Toufik Abdul-Rahman et al.
CURRENT PROBLEMS IN CARDIOLOGY (2022)
Screening of phytochemical compounds ofTinospora cordifoliafor their inhibitory activity on SARS-CoV-2: anin silicostudy
S. Krupanidhi et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Bioactivity of Dietary Polyphenols: The Role in LDL-C Lowering
Peng Sun et al.
FOODS (2021)
Identification of the most potent acetylcholinesterase inhibitors from plants for possible treatment of Alzheimer's disease: a computational approach
Bishajit Sarkar et al.
EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS (2021)
Docking studies and molecular dynamics simulations of the binding characteristics of waldiomycin and its methyl ester analog toStaphylococcus aureushistidine kinase
Awwad Radwan et al.
PLOS ONE (2020)
Structurally Different Flavonoid Subclasses Attenuate High-Fat and High-Fructose Diet Induced Metabolic Syndrome in Rats
Jianan Zhang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2018)
Phytochemical Profile, Antioxidant and Antidiabetic Activities of Adansonia digitata L. (Baobab) from Mali, as a Source of Health-Promoting Compounds
Alessandra Braca et al.
MOLECULES (2018)
Natural Inhibitors of HMG-CoA ReductaseAn Insilico Approach Through Molecular Docking and Simulation Studies
Subramanian Suganya et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Shape based virtual screening and molecular docking towards designing novel pancreatic lipase inhibitors
Ganesh Kumar Veeramachaneni et al.
BIOINFORMATION (2015)
Hyperlipidemia as a Risk Factor for Cardiovascular Disease
Robert H. Nelson
PRIMARY CARE (2013)
FDA Drug Safety Communications: A Narrative Review and Clinical Considerations for Older Adults
Zachary A. Marcum et al.
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (2012)
Statin inhibition of HMG-CoA reductase: a 3-dimensional view
E Istvan
ATHEROSCLEROSIS SUPPLEMENTS (2003)
Managing hyperlipidemia: Current and future roles of HMG-CoA reductase inhibitors
LM Lopez
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2002)